Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Clelia Geraci"'
Autor:
Estevão Carlos Silva Barcelos, Chiara Rompietti, Francesco Maria Adamo, Erica Dorillo, Filomena De Falco, Beatrice Del Papa, Stefano Baldoni, Manuel Nogarotto, Angela Esposito, Silvia Capoccia, Clelia Geraci, Daniele Sorcini, Arianna Stella, Roberta Arcaleni, Valentina Tini, Flávia Imbroisi Valle Errera, Emanuela Rosati, Paolo Sportoletti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionConstitutive activation of NOTCH1-wild-type (NT1-WT) signaling is associated with poor outcomes in chronic lymphocytic leukemia (CLL), and NOTCH1 mutation (c.7541_7542delCT), which potentiates NOTCH1 signaling, worsens the prognosis. Howe
Externí odkaz:
https://doaj.org/article/42a87a28abc246f28270a9eea157bbfb
Autor:
Daniele Sorcini, Filomena De Falco, Marco Gargaro, Silvia Bozza, Valerio Guarente, Valeria Cardinali, Arianna Stella, Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Chiara Rompietti, Erica Dorillo, Clelia Geraci, Angela Esposito, Roberta Arcaleni, Silvia Capoccia, Maria Grazia Mameli, Alessandro Graziani, Lorenzo Moretti, Alessandra Cipiciani, Carlo Riccardi, Antonella Mencacci, Francesca Fallarino, Emanuela Rosati, Paolo Sportoletti
Publikováno v:
British Journal of Haematology. 201:45-57
In chronic lymphocytic leukaemia (CLL) the efficacy of SARS-CoV-2 vaccination remains unclear as most studies have focused on humoral responses. Here we comprehensively examined humoral and cellular responses to vaccine in CLL patients. Seroconversio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c356fac7b0824446bb2966e1289a4ea
https://doi.org/10.1111/bjh.18602
https://doi.org/10.1111/bjh.18602
Autor:
Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Filomena Falco, Erica Dorillo, Chiara Rompietti, Daniele Sorcini, Arianna Stella, Beatrice Del Papa, Stefano Baldoni, Angela Esposito, Clelia Geraci, Roberta Arcaleni, Chiara Pennetta, Francesco Ragonese, Lorenzo Moretti, Mariagrazia Mameli, Mauro Ianni, Emanuela Rosati, Bernard Fioretti, Paolo Sportoletti
Background Chronic lymphocytic leukemia (CLL) is an incurable disorder associated with alterations in several pathways essential for survival and proliferation. Despite the advances obtained in CLL therapy with the new target agents, in some cases re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42854700a1804eb917ccf37ee2596b9f
https://doi.org/10.21203/rs.3.rs-2897424/v1
https://doi.org/10.21203/rs.3.rs-2897424/v1
